Thomas Charpeaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Thomas Charpeaud has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Marion Leboyer
Fondation FondaMental, Creteil, France
3 shared publications - Pierre-Michel Llorca
Université Clermont Auvergne, Clermont-Ferrand, France
3 shared publications - Emmanuel Haffen
Université Marie et Louis Pasteur, INSERM, UMR 1322 LINC, Besançon, France
2 shared publications - Frédéric Haesebaert
Affiliations Université Claude Bernard Lyon, CNRS, INSERM, Centre de Recherche en Neurosciences de Lyon CRNL U1028 UMR5292, PSYR2, Bron, France, Centre Hospitalier le Vinatier, Bron, France
2 shared publications P.-M. Llorca
CHU de Clermont-Ferrand, centre expert dépression résistante FondaMental, service de psychiatrie de l'adulte B, 63003 Clermont-Ferrand, France
2 shared publications- Pierre-Michel Llorca
Fondation FondaMental, Créteil, France; CMP B, CHU, EA 7280 Faculté de Médecine, Université d'Auvergne, BP 69 63003 Clermont-Ferrand Cedex 1, France
2 shared publications
Latest Publications
- Open Access
- 26 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 624
Repetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis
Addiction is a mental disorder with limited available treatment options. The therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) on it, by targeting craving in particular, has been explored with heterogenous results. This meta-analysis uses updated evidence to assess overall rTMS efficacy on craving, differential effects between addiction types clustered into three groups (depressant (alcohol, cannabis, opiate), stimulant (nicotine, cocaine, methamphetamine), and behavioral addiction (gambling, eating disorder)), and stimulation settings. Studies on substance use, gambling, and eating disorders are included, with unrestricted stimulation settings, by searching the PubMed, Embase, PsycINFO, and Cochrane databases up to 30 April 2020. A total of 34 eligible studies (42 units of analysis) were identified. Because of highly significant heterogeneity in primary results, a sensitivity analysis was performed on a remaining sample of 26 studies (30 units of analysis). Analyses performed using random effects model revealed a small effect size favoring active rTMS over shamTMS stimulation in the reduction in craving. We found a significant difference between addiction types, with a persistent small effect only for stimulant and behavioral groups. In these groups we found no difference between the different combinations of target and frequency of stimulation, but a significant correlation between number of sessions and craving reduction. In conclusion, efficacy of rTMS on craving in stimulant and behavioral addiction was highlighted, but recommendations on optimal stimulation settings and its clinical application await further research.
- 26 January 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (3) , 624
Open AccessRepetitive Transcranial Magnetic Stimulation (rTMS) as a Promising Treatment for Craving in Stimulant Drugs and Behavioral Addiction: A Meta-Analysis
Addiction is a mental disorder with limited available treatment options. The therapeutic potential of repetitive transcranial magnetic stimulation (rTMS) on it, by targeting craving in particular, has been explored with heterogenous results. This meta-analysis uses updated evidence to assess overall rTMS efficacy on craving, differential effects between addiction types clustered into three groups (depressant (alcohol, cannabis, opiate), stimulant (nicotine, cocaine, methamphetamine), and behavioral addiction (gambling, eating disorder)), and stimulation settings. Studies on substance use, gambling, and eating disorders are included, with unrestricted stimulation settings, by searching the PubMed, Embase, PsycINFO, and Cochrane databases up to 30 April 2020. A total of 34 eligible studies (42 units of analysis) were identified. Because of highly significant heterogeneity in primary results, a sensitivity analysis was performed on a remaining sample of 26 studies (30 units of analysis). Analyses performed using random effects model revealed a small effect size favoring active rTMS over shamTMS stimulation in the reduction in craving. We found a significant difference between addiction types, with a persistent small effect only for stimulant and behavioral groups. In these groups we found no difference between the different combinations of target and frequency of stimulation, but a significant correlation between number of sessions and craving reduction. In conclusion, efficacy of rTMS on craving in stimulant and behavioral addiction was highlighted, but recommendations on optimal stimulation settings and its clinical application await further research.
- 1 September 2017
- Published by Elsevier in L'Encéphale
- Vol. 43 (4) , S1-S24
Prise en charge des troubles dépressifs résistants : recommandations françaises formalisées par des experts de l’AFPBN et de la fondation FondaMental
- 1 September 2017
- Published by Elsevier in L'Encéphale
- Vol. 43 (4) , S1-S24
Prise en charge des troubles dépressifs résistants : recommandations françaises formalisées par des experts de l’AFPBN et de la fondation FondaMental
- 1 March 2016
- Published by Elsevier in La Presse Médicale
- Vol. 45 (3) , 329-337
Dépression résistante : les stratégies de changement et d’association de médicaments antidépresseurs
- 1 March 2016
- Published by Elsevier in La Presse Médicale
- Vol. 45 (3) , 329-337
Dépression résistante : les stratégies de changement et d’association de médicaments antidépresseurs
- 1 February 2015
- Published by Elsevier in Annales Médico-psychologiques, revue psychiatrique
- Vol. 173 (1) , 97-100
Intérêt de l’éducation thérapeutique chez les malades souffrant de schizophrénie : le programme SCHIZ’EDUC
- 1 February 2015
- Published by Elsevier in Annales Médico-psychologiques, revue psychiatrique
- Vol. 173 (1) , 97-100
Intérêt de l’éducation thérapeutique chez les malades souffrant de schizophrénie : le programme SCHIZ’EDUC
- Open Access
- 17 March 2014
- Published by Springer Nature in BMC Psychiatry
- Vol. 14 (1) , 78
Rural-urban variation in incidence of psychosis in France: a prospective epidemiologic study in two contrasted catchment areas
The aim of our study is to provide data on the incidence of psychotic disorders in France and compare the incidence rates in populations with different levels of urbanization. We prospectively included the incident cases of psychotic disorders from two catchment areas with contrasted levels of urbanization. In the more rural area, we also calculated incidence rates in three different groups of population defined by the size of towns in which they live (small, medium and large towns). The annual incidence of psychosis was greater in the urban area (36.02/100000 person-year at risk) than in the rural area (17.2/100000 person-year at risk). Non-affective psychoses were the majority of cases and their incidence was greater in males and younger subjects. The affective psychoses were slightly more frequent in women and showed less variation with age. In the rural centre, greater levels of urbanicity were associated with an increase in the incidence of all psychoses (affective and non-affective). Our study confirms previous observations of increased incidence rates for non-affective psychoses in the more urbanized areas and suggests that a similar pattern might be present for affective psychoses.
- 17 March 2014
- Published by Springer Nature in BMC Psychiatry
- Vol. 14 (1) , 78
Open AccessRural-urban variation in incidence of psychosis in France: a prospective epidemiologic study in two contrasted catchment areas
The aim of our study is to provide data on the incidence of psychotic disorders in France and compare the incidence rates in populations with different levels of urbanization. We prospectively included the incident cases of psychotic disorders from two catchment areas with contrasted levels of urbanization. In the more rural area, we also calculated incidence rates in three different groups of population defined by the size of towns in which they live (small, medium and large towns). The annual incidence of psychosis was greater in the urban area (36.02/100000 person-year at risk) than in the rural area (17.2/100000 person-year at risk). Non-affective psychoses were the majority of cases and their incidence was greater in males and younger subjects. The affective psychoses were slightly more frequent in women and showed less variation with age. In the rural centre, greater levels of urbanicity were associated with an increase in the incidence of all psychoses (affective and non-affective). Our study confirms previous observations of increased incidence rates for non-affective psychoses in the more urbanized areas and suggests that a similar pattern might be present for affective psychoses.
- 1 February 2014
- Published by Elsevier in L'Encéphale
- Vol. 40 (1) , 62-73
Efficacité de l’aripiprazole dans le traitement de la schizophrénie : quelle dose pour quel effet ?
- 1 February 2014
- Published by Elsevier in L'Encéphale
- Vol. 40 (1) , 62-73
Efficacité de l’aripiprazole dans le traitement de la schizophrénie : quelle dose pour quel effet ?